Module 1: Genomics, Proteomics, Metabolomics si Bioinformatics: |
|
1.1. |
Development of Bioinformatics Tools for genomics, proteomics, glicomics etc - IB |
1.2. |
Molecular modelling of protein structure and interaction with ligands - IB |
1.3. |
Genomics applications in organ and cellular transplant - Inst Fundeni |
1.4. |
Desmoplastic reaction and pancreatic cancer progression - Inst Fundeni |
1.5. |
Metabolomics and molecular markers for taxonomic recognition - USAMV Cluj |
1.6. |
Molecular markers for food authentification - USAMV Cluj |
1.7. |
Applied chemometry aplicata for food authentification - USAMV Cluj |
|
1.8. |
The structure and function of cellular signalling enzymes - IB |
|
|
Module 2: the Molecular Biology of the Cell: |
2.1. |
The cellular homeostasis of proteins in normal and patological states - IB |
2.2. |
Molecular mechanisms of ER stress and pancreatic beta cells - IB |
2.3 |
Unfolded protein accumulation in cancer and hipoxia models - IB |
2.4. |
The expression of glycosylation products receptors in inflamation and diabet - IB |
2.5. |
The morfology and intracellular trafic of Hep B & C virus - IB |
2.6. |
Mesenchimal Stem Cells and tumoral fibroblasts comparative studies - UMF Timisoara |
2.7. |
Mesenchimal Stem Cell differentiation toward adipocytes - UMF Timisoara |
2.8. |
The cellular response to abiotic stress in S.cerevisiae - UB |
|
|
Module 3: Cellular Therapies: |
3.1. |
Hematopoietic Stem Cell Therapies in hepatic diseases - Inst Fundeni |
3.2. |
Clinical applications of the Cellular Therapies in hepatic diseases - Inst Fundeni |
3.3. |
Mesenchimal Stem Cell Therapies in re-epithelization processes - UMF Timisoara |
3.4. |
pancreatic beta cells in diabet and regenerative medicine - Inst Fundeni |
3.4.1. |
Methods for improving pancreatic islands viability after isolation and transplant. |
3.4.2. |
Biomarker based noninvasive methods for pancreatic islands measurement and their function assesment.
|
3.4.3. |
The engineering of a glucose-responsive insuline secretory cell-line for therapeutic application; |
3.4.4. |
Exocytosis and fussion of secretory granulae with the cellmembrane in pancreatic beta cells lines - IB |
3.5. |
Laser cell transfer for tissular engineering and organ reconstruction - INCD Laser Physics |
|
Module 4: Biomaterials, nanostructures and pharmacophores: |
4.1. |
Antiviral drug design for hep B and C viruses - IB |
Dezvoltare medicamente antivirale fata de virusului hepatitei B si C - IB
4.2. |
Nanostructures for controlled drug release - INCD Laser Physics |
Nanostructuri pentru eliberare controlata de medicamente - INCD Laser Physics
4.3. |
Directional synthesis and screening of stresso-protective compoundse - UB |
Sinteza dirijata si screeningul unor compusi cu activitate streso-protectoare - UB
4.4. |
Lasser applications in nanostructures for controlled drug administration, implants and tissue reconstruction - INCD Laser Physics |
4.5. |
Biomaterial laser nanostructuring for pharmaceutical applications - INCD Laser Physics |
4.6. |
Implant nanostructure biocompatibility si bioactivity - INCD Laser Physics |